SLC13A2 and Calcium oxalate nephrolithiasis: This mutation impairs the regulation of NADC-1-mediated citrate transport by weakening the interaction between the STAS domain of SLC26A6 and NADC-1, causing hypocitraturia and occurrence of calcium oxalate kidney stones.